Product Information
DICLOFENAC POT 50 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.1125 per EA under NDC 70710183201. Its NADAC has been published 214 times since Aug 31, 2022.
FDA first approved this application on May 11, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710183201
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DICLOFENAC POTASSIUMApproval Type
Generic (ANDA)
FDA Application
ANDA215750FDA Approved
5/11/2022
TE Code
AB
On Market Since
5/12/2022
Pharmacological Classes
Price Statistics
The NADAC for DICLOFENAC POT 50 MG TABLET has been published 214 times since Aug 31, 2022, and over the history we have for it it has declined 46.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1125 per EA |
|---|---|
| All-time high | $0.2113 (Aug 16, 2023) |
| All-time low | $0.0931 (Nov 20, 2024) |
| 52-week high | $0.1336 |
| 52-week low | $0.0982 |
| Median price | $0.1530 |
| Average price | $0.1537 |
| Largest weekly change | -51.3% (Nov 20, 2024) |
| Weeks tracked | 214 |
| Tracking since | Aug 31, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Diclofenac Potassium Tablets market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Diclofenac Potassium Tablets market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DICLOFENAC POT 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DICLOFENAC POT 50 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.1125 per EA (NDC 70710183201), effective Sep 30, 2026.
How has the price of DICLOFENAC POT 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for DICLOFENAC POT 50 MG TABLET has declined 46.3%. It has been tracked across 214 weekly CMS publications since Aug 31, 2022.
What are the highest and lowest recorded NADAC prices for DICLOFENAC POT 50 MG TABLET?
Since Aug 31, 2022, the NADAC for DICLOFENAC POT 50 MG TABLET has ranged from a low of $0.0931 (Nov 20, 2024) to a high of $0.2113 (Aug 16, 2023), with a median of $0.1530 per EA.
Are there cheaper alternatives to DICLOFENAC POT 50 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of DICLOFENAC POT 50 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DICLOFENAC POT 50 MG TABLET?
DICLOFENAC POT 50 MG TABLET (NDC 70710183201) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.